Clinical research and progress of stereotactic radiotherapy for early stage non-small-cell lung cancer
10.12025/j.issn.1008-6358.2016.20160605
- VernacularTitle:早期肺癌立体定向放射治疗的临床研究进展
- Author:
Lu-Xi YE
1
;
Jian HE
Author Information
1. 复旦大学附属中山医院放疗科
- Keywords:
early stage lung cancer;
stereotactic body radiotherapy;
immunology
- From:
Chinese Journal of Clinical Medicine
2016;23(6):823-828
- CountryChina
- Language:Chinese
-
Abstract:
Stereotactic body radiotherapy (SBRT ) and stereotactic ablative radiotherapy (SABR) ,methods of high local precision ,have been widely used in early stage inoperable non‐small‐cell lung cancer (NSCLC) patients .In some clinical trials ,the 3‐year local control rate and 3‐year survival rate were close to the effect of surgery ,and had little effect on the pulmonary function of patients .This paper briefly reviews the clinical practice and research progress of SBRT /SABR in early stage NSCLC .
